Facing The Reality Of Drug Resistant Tuberculosis In India


Facing The Reality Of Drug Resistant Tuberculosis In India
DOWNLOAD eBooks

Download Facing The Reality Of Drug Resistant Tuberculosis In India PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Facing The Reality Of Drug Resistant Tuberculosis In India book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page





Facing The Reality Of Drug Resistant Tuberculosis In India


Facing The Reality Of Drug Resistant Tuberculosis In India
DOWNLOAD eBooks

Author : Institute of Medicine
language : en
Publisher: National Academies Press
Release Date : 2012-08-20

Facing The Reality Of Drug Resistant Tuberculosis In India written by Institute of Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012-08-20 with Medical categories.


An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a majority of TB cases, resistance to these antibiotics has emerged over the years, resulting in the growing spread of multidrug-resistant (MDR) TB. Due to challenges in timely and accurate diagnosis of drug-resistant TB, length and tolerability of treatment regimens, and expense of second-line anti-TB drugs, effectively controlling the disease requires complex public health interventions. The IOM Forum on Drug Discovery, Development, and Translation held three international workshops to gather information from local experts around the world on the threat of drug resistant TB and how the challenges it presents can be met. Workshops were held in South Africa and Russia in 2010. The third workshop was held April 18-19, 2011, in New Delhi, India, in collaboration with the Indian National Science Academy and the Indian Council of Medical Research. The aim of the workshop was to highlight key challenges to controlling the spread of drug-resistant strains of TB in India and to discuss strategies for advancing and integrating local and international efforts to prevent and treat drug-resistant TB. This document summarizes the workshop.



Facing The Reality Of Drug Resistant Tuberculosis In India


Facing The Reality Of Drug Resistant Tuberculosis In India
DOWNLOAD eBooks

Author : Institute of Medicine
language : en
Publisher: National Academies Press
Release Date : 2012-07-20

Facing The Reality Of Drug Resistant Tuberculosis In India written by Institute of Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012-07-20 with Medical categories.


An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a majority of TB cases, resistance to these antibiotics has emerged over the years, resulting in the growing spread of multidrug-resistant (MDR) TB. Due to challenges in timely and accurate diagnosis of drug-resistant TB, length and tolerability of treatment regimens, and expense of second-line anti-TB drugs, effectively controlling the disease requires complex public health interventions. The IOM Forum on Drug Discovery, Development, and Translation held three international workshops to gather information from local experts around the world on the threat of drug resistant TB and how the challenges it presents can be met. Workshops were held in South Africa and Russia in 2010. The third workshop was held April 18-19, 2011, in New Delhi, India, in collaboration with the Indian National Science Academy and the Indian Council of Medical Research. The aim of the workshop was to highlight key challenges to controlling the spread of drug-resistant strains of TB in India and to discuss strategies for advancing and integrating local and international efforts to prevent and treat drug-resistant TB. This document summarizes the workshop.



Facing The Reality Of Drug Resistant Tuberculosis In India


Facing The Reality Of Drug Resistant Tuberculosis In India
DOWNLOAD eBooks

Author :
language : en
Publisher:
Release Date : 2012

Facing The Reality Of Drug Resistant Tuberculosis In India written by and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012 with Drug resistance categories.


"An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a majority of TB cases, resistance to these antibiotics has emerged over the years, resulting in the growing spread of multidrug-resistant (MDR) TB. Due to challenges in timely and accurate diagnosis of drug-resistant TB, length and tolerability of treatment regimens, and expense of second-line anti-TB drugs, effectively controlling the disease requires complex public health interventions. The IOM Forum on Drug Discovery, Development, and Translation held three international workshops to gather information from local experts around the world on the threat of drug resistant TB and how the challenges it presents can be met. Workshops were held in South Africa and Russia in 2010. The third workshop was held April 18-19, 2011, in New Delhi, India, in collaboration with the Indian National Science Academy and the Indian Council of Medical Research. The aim of the workshop was to highlight key challenges to controlling the spread of drug-resistant strains of TB in India and to discuss strategies for advancing and integrating local and international efforts to prevent and treat drug-resistant TB. This document summarizes the workshop"--Publisher's description



Facing The Reality Of Drug Resistant Tuberculosis


Facing The Reality Of Drug Resistant Tuberculosis
DOWNLOAD eBooks

Author :
language : en
Publisher:
Release Date : 2012

Facing The Reality Of Drug Resistant Tuberculosis written by and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012 with Antitubercular agents categories.




Developing And Strengthening The Global Supply Chain For Second Line Drugs For Multidrug Resistant Tuberculosis


Developing And Strengthening The Global Supply Chain For Second Line Drugs For Multidrug Resistant Tuberculosis
DOWNLOAD eBooks

Author : Institute of Medicine
language : en
Publisher: National Academies Press
Release Date : 2013-03-06

Developing And Strengthening The Global Supply Chain For Second Line Drugs For Multidrug Resistant Tuberculosis written by Institute of Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2013-03-06 with Medical categories.


To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resistant tuberculosis (MDR TB)-a disease caused by strains of Mycobacterium tuberculosis (M.tb.) resistant to two primary TB drugs (isoniazid and rifampicin)-face lengthy treatment regimens of 2 years or more with daily, directly observed treatment (DOT) with SLDs that are less potent, more toxic, and more expensive than those used to treat drug-susceptible TB. From 2000 to 2009, only 0.2-0.5 percent of the estimated 5 million MDR TB cases globally were treated with drugs of known quality and in programs capable of delivering appropriate care (Keshavjee, 2012). The vast majority of MDR TB patients either died from lack of treatment or contributed to the spread of MDR TB in their communities. A strengthened global supply chain for SLDs could save lives by consistently delivering high quality medicines to more of the people who need them. This public workshop explored innovative solutions to the problem of how to get the right SLDs for MDR TB to people who critically need them. More specifically, the workshop examined current problems and potential opportunities for coordinated international efforts to ensure that a reliable and affordable supply of high-quality SLDs is available. Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis: Workshop Summary covers the objectives of the workshop, which were to review: -To what extent and in what ways current mechanisms are or are not effectively accomplishing what is needed, including consideration of bottlenecks. -The advantages and disadvantages of centralization in the management of the global drug supply chain, and potential decentralized approaches to improve operations of the supply chain. -What can be learned from case studies and examples from other diseases (e.g., the Affordable Medicines Facility-malaria (AMFm) and the U.S. President's Emergency Plan for AIDS Relief [PEPFAR]) - The current allocation of responsibilities and roles of the private (including industry and nonprofit public health organizations) and public sectors, and examination of opportunities for enhancing and optimizing collaboration -Identification of potential innovative solutions to the problem



Ecology Of Tuberculosis In India


Ecology Of Tuberculosis In India
DOWNLOAD eBooks

Author : Bikramaditya K. Choudhary
language : en
Publisher: Springer Nature
Release Date : 2021-03-19

Ecology Of Tuberculosis In India written by Bikramaditya K. Choudhary and has been published by Springer Nature this book supported file pdf, txt, epub, kindle and other format this book has been release on 2021-03-19 with Social Science categories.


The book addresses the issue of disease diffusion across the geographical span of India during the colonial period. Based on archival records, it analyses colonial economic policies and their implications for the spread of the disease across different regions of India as well as the role of the military in disease spread. It adds a new dimension to the understanding of the spread of TB in colonial India. The book also discusses the concept of the meaning of illness for different cohorts of TB patients. Based on narratives, it brings to readers the social and cultural dimensions that are responsible for the prevalence of the disease, despite having vaccination and medication available for more than half a century. The book will be beneficial to health and medical geographers and will bring new insights in historical geography as well as the history of medicine, by incorporating policy changes and their implication in disease spread. Sociologists and public health professionals will find narratives of patients interesting and useful for furthering their understanding.



Recent Developments In Applied Microbiology And Biochemistry


Recent Developments In Applied Microbiology And Biochemistry
DOWNLOAD eBooks

Author : Viswanath Buddolla
language : en
Publisher: Academic Press
Release Date : 2020-10-15

Recent Developments In Applied Microbiology And Biochemistry written by Viswanath Buddolla and has been published by Academic Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-10-15 with Medical categories.


Recent Developments in Applied Microbiology and Biochemistry, Vol. 2, provides a comprehensive treatment and understanding on application oriented microbial concepts, giving readers insights into recent developments in microbial biotechnology and medical, agricultural and environmental microbiology. Discusses microbial proteome analyses and their importance in medical microbiology Explores emerging trends in the prevention of current global health problems, such as cancer, obesity and immunity Shows recent approaches in the production of novel enzymes from environmental samples by enrichment culture and metagenomics approaches Guides readers through the status and recent developments in analytical methods for the detection of foodborne microorganisms



The Global Crisis Of Drug Resistant Tuberculosis And Leadership Of China And The Brics


The Global Crisis Of Drug Resistant Tuberculosis And Leadership Of China And The Brics
DOWNLOAD eBooks

Author : Institute of Medicine
language : en
Publisher: National Academies Press
Release Date : 2014-03-28

The Global Crisis Of Drug Resistant Tuberculosis And Leadership Of China And The Brics written by Institute of Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014-03-28 with Medical categories.


Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Medicine has hosted or co-hosted six domestic and international workshops addressing the global crisis of drug-resistant TB, with special attention to the BRICS countries - Brazil, Russia, India, China, and South Africa. The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS is the summary of a workshop convened to address the current status of drug-resistant TB globally and in China. This report considers lessons learned from high burden countries; highlights global challenges to controlling the spread of drug-resistant strains; and discusses innovative strategies to advance and harmonize local and international efforts to prevent and treat drug-resistant TB. Additionally, the report examines the problem of MDR TB and emergent TB strains that are potentially untreatable with drugs available and considers the critical leadership role of the BRICS countries in addressing the threats and opportunities in drug-resistant TB.



Disease Control Priorities Third Edition Volume 6


Disease Control Priorities Third Edition Volume 6
DOWNLOAD eBooks

Author : King K. Holmes
language : en
Publisher: World Bank Publications
Release Date : 2017-11-06

Disease Control Priorities Third Edition Volume 6 written by King K. Holmes and has been published by World Bank Publications this book supported file pdf, txt, epub, kindle and other format this book has been release on 2017-11-06 with Medical categories.


Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.



Global Tuberculosis Control


Global Tuberculosis Control
DOWNLOAD eBooks

Author : World Health Organization
language : en
Publisher: World Health Organization
Release Date : 2010

Global Tuberculosis Control written by World Health Organization and has been published by World Health Organization this book supported file pdf, txt, epub, kindle and other format this book has been release on 2010 with Medical categories.


The World Health Organization (WHO) has published an annual report on global control of tuberculosis (TB) every year since 1997. The main purpose of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic and progress made in TB care and control at global, regional and country levels. This fifteenth annual report contains more up-to-date information than any previous report in the series, following earlier data collection and the completion of the production cycle within a calendar year. This report includes the same wealth of information as previous reports in the series, but three new features are worth highlighting. First, the data are more up-to-date than those included in previous reports. Data up to and including 2009 are presented for almost all key indicators; financial data extend to 2011. Second, results from several analyses undertaken for the first time in 2010 are included. Examples are: (i) for each of the 22 high-burden countries (HBCs), trends in rates of TB incidence and mortality since 1990 combined with projections of whether the target of halving the 1990 mortality rate by 2015 will be achieved; (ii) estimates of the lives saved by TB control between 1995 and 2009 and projections of the additional lives that could be saved up to 2015, including separate estimates for women and children; (iii) assessment of progress in implementing and financing TB care and control against the targets included in a just-released and updated version of the Global Plan to Stop TB; and (iv) a new and compelling compilation of data showing the contribution that PP PP M can make to case detection. Third, country profiles are available for all countries (rather than the 22 HBCs only) and can be downloaded online at www.who.int/tb/data, always drawing on the latest data available in WHO s global TB database. Annex 1 explains the methods that were used to produce estimates of disease burden. Annex 2 contains summary tables that provide global, regional and country-specific data for the main indicators of interest. Country profiles for all countries are available online at www.who.int/tb/data; their content is advertised in Annex 3.